4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide

C160H206BrCl2F3N16O33S7 — CID 159625063

About 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide

4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide (PubChem CID 159625063) has the molecular formula C160H206BrCl2F3N16O33S7 and a molecular weight of 3313.76 g/mol. Its IUPAC name is 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide.

Molecular Properties

• Compound Name: 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide
• PubChem CID: 159625063
• Molecular Formula: C160H206BrCl2F3N16O33S7
• Molecular Weight: 3313.76 g/mol
• Exact Mass: 3309.15
• IUPAC Name: 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide
• SMILES: CC(C)(NS(=O)(=O)c1cccc(C(F)(F)F)c1)C(=O)CC1C2CC3CC1CC(C(N)=O)(C3)C2.CC(C)(NS(=O)(=O)c1ccccc1C#N)C(=O)CC1C2CC3CC1CC(C(N)=O)(C3)C2.COc1cc([N+](=O)[O-])ccc1S(=O)(=O)NC(C)(C)C(=O)CC1C2CC3CC1CC(C(N)=O)(C3)C2.COc1ccc(S(=O)(=O)NC(C)(C)C(=O)CC2C3CC4CC2CC(C(N)=O)(C4)C3)c(OC)c1.Cc1c(Cl)cccc1S(=O)(=O)NC1(C(=O)CC2C3CC4CC2CC(C(N)=O)(C4)C3)CC1.NC(=O)C12CC3CC(C1)C(CC(=O)C1(NS(=O)(=O)c4ccccc4Br)CC1)C(C3)C2.NC(=O)C12CC3CC(C1)C(CC(=O)C1(NS(=O)(=O)c4ccccc4Cl)CC1)C(C3)C2
• InChI: InChI=1S/C24H34N2O6S.C23H29ClN2O4S.C23H29F3N2O4S.C23H31N3O7S.C23H29N3O4S.C22H27BrN2O4S.C22H27ClN2O4S/c1-23(2,26-33(29,30)20-6-5-17(31-3)9-19(20)32-4)21(27)10-18-15-7-14-8-16(18)13-24(11-14,12-15)22(25)28;1-13-18(24)3-2-4-19(13)31(29,30)26-23(5-6-23)20(27)9-17-15-7-14-8-16(17)12-22(10-14,11-15)21(25)28;1-21(2,28-33(31,32)17-5-3-4-16(8-17)23(24,25)26)19(29)9-18-14-6-13-7-15(18)12-22(10-13,11-14)20(27)30;1-22(2,25-34(31,32)19-5-4-16(26(29)30)8-18(19)33-3)20(27)9-17-14-6-13-7-15(17)12-23(10-13,11-14)21(24)28;1-22(2,26-31(29,30)19-6-4-3-5-15(19)13-24)20(27)9-18-16-7-14-8-17(18)12-23(10-14,11-16)21(25)28;2*23-17-3-1-2-4-18(17)30(28,29)25-22(5-6-22)19(26)9-16-14-7-13-8-15(16)12-21(10-13,11-14)20(24)27/h5-6,9,14-16,18,26H,7-8,10-13H2,1-4H3,(H2,25,28);2-4,14-17,26H,5-12H2,1H3,(H2,25,28);3-5,8,13-15,18,28H,6-7,9-12H2,1-2H3,(H2,27,30);4-5,8,13-15,17,25H,6-7,9-12H2,1-3H3,(H2,24,28);3-6,14,16-18,26H,7-12H2,1-2H3,(H2,25,28);2*1-4,13-16,25H,5-12H2,(H2,24,27)
• InChIKey: MOJOVWADNLAFCG-UHFFFAOYSA-N
• XLogP: 20.88
• TPSA: 838.93 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 34
• Rotatable Bonds: 53
• Heavy Atoms: 222
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3313.76
LogP ≤ 5	20.88
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	34

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide?

The IUPAC name of 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide (CID 159625063) is 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide.

What is the SMILES notation for 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide?

The canonical SMILES for 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide is CC(C)(NS(=O)(=O)c1cccc(C(F)(F)F)c1)C(=O)CC1C2CC3CC1CC(C(N)=O)(C3)C2.CC(C)(NS(=O)(=O)c1ccccc1C#N)C(=O)CC1C2CC3CC1CC(C(N)=O)(C3)C2.COc1cc([N+](=O)[O-])ccc1S(=O)(=O)NC(C)(C)C(=O)CC1C2CC3CC1CC(C(N)=O)(C3)C2.COc1ccc(S(=O)(=O)NC(C)(C)C(=O)CC2C3CC4CC2CC(C(N)=O)(C4)C3)c(OC)c1.Cc1c(Cl)cccc1S(=O)(=O)NC1(C(=O)CC2C3CC4CC2CC(C(N)=O)(C4)C3)CC1.NC(=O)C12CC3CC(C1)C(CC(=O)C1(NS(=O)(=O)c4ccccc4Br)CC1)C(C3)C2.NC(=O)C12CC3CC(C1)C(CC(=O)C1(NS(=O)(=O)c4ccccc4Cl)CC1)C(C3)C2.

What is the InChIKey of 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide?

The InChIKey is MOJOVWADNLAFCG-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H34N2O6S.C23H29ClN2O4S.C23H29F3N2O4S.C23H31N3O7S.C23H29N3O4S.C22H27BrN2O4S.C22H27ClN2O4S/c1-23(2,26-33(29,30)20-6-5-17(31-3)9-19(20)32-4)21(27)10-18-15-7-14-8-16(18)13-24(11-14,12-15)22(25)28;1-13-18(24)3-2-4-19(13)31(29,30)26-23(5-6-23)20(27)9-17-15-7-14-8-16(17)12-22(10-14,11-15)21(25)28;1-21(2,28-33(31,32)17-5-3-4-16(8-17)23(24,25)26)19(29)9-18-14-6-13-7-15(18)12-22(10-13,11-14)20(27)30;1-22(2,25-34(31,32)19-5-4-16(26(29)30)8-18(19)33-3)20(27)9-17-14-6-13-7-15(17)12-23(10-13,11-14)21(24)28;1-22(2,26-31(29,30)19-6-4-3-5-15(19)13-24)20(27)9-18-16-7-14-8-17(18)12-23(10-14,11-16)21(25)28;2*23-17-3-1-2-4-18(17)30(28,29)25-22(5-6-22)19(26)9-16-14-7-13-8-15(16)12-21(10-13,11-14)20(24)27/h5-6,9,14-16,18,26H,7-8,10-13H2,1-4H3,(H2,25,28);2-4,14-17,26H,5-12H2,1H3,(H2,25,28);3-5,8,13-15,18,28H,6-7,9-12H2,1-2H3,(H2,27,30);4-5,8,13-15,17,25H,6-7,9-12H2,1-3H3,(H2,24,28);3-6,14,16-18,26H,7-12H2,1-2H3,(H2,25,28);2*1-4,13-16,25H,5-12H2,(H2,24,27).

What are the key properties of 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide?

4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide has a molecular weight of 3313.76 g/mol, XLogP of 20.88, 53 rotatable bonds, 14 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[2-[1-[(2-bromophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(3-chloro-2-methylphenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[2-[1-[(2-chlorophenyl)sulfonylamino]cyclopropyl]-2-oxoethyl]adamantane-1-carboxamide;4-[3-[(2-cyanophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2,4-dimethoxyphenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-[(2-methoxy-4-nitrophenyl)sulfonylamino]-3-methyl-2-oxobutyl]adamantane-1-carboxamide;4-[3-methyl-2-oxo-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]butyl]adamantane-1-carboxamide is sourced from PubChem (CID 159625063), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).